Efficacy of Combined Therapy with Liposome-Encapsulated Meglumine Antimoniate and Allopurinol in Treatment of Canine Visceral Leishmaniasis

An innovative liposomal formulation of meglumine antimoniate (LMA) was recently reported to promote both long-term parasite suppression and reduction of infectivity to sand flies in dogs with visceral leishmaniasis. However, 5 months after treatment, parasites were still found in the bone marrow of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: da Silva, Sydnei M., Amorim, Izabela F. G., Ribeiro, Raul R., Azevedo, Erly G., Demicheli, Cynthia, Melo, Maria N., Tafuri, Wagner L., Gontijo, Nelder F., Michalick, Marilene S. M., Frézard, Frédéric
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3370762/
https://ncbi.nlm.nih.gov/pubmed/22411610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00208-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares